In a Q&A, Brian Wojeck, MD, MPH, discusses how weight and sleep impact each other and how discovering connections between diabetes, obesity, and sleep disorders can lead to better treatment.
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
emphasizing the potential independent impact of UPFs on early obesity risk, although our findings are observational, so we cannot draw causal conclusions.” The study was published online on ...
Here, clinicians can draw upon a rich trove of recent data linking ... rates were higher among patients taking them for obesity rather than type 2 diabetes. Jaisinghani pointed to high costs ...
Lemon and honey are a popular weight loss concoction that has been doing the rounds for ages. But do they actually work?
And so, another working week will soon draw to a close ... a boost for the company amid a race to develop next-generation obesity treatments, STAT tells us. Novo said that patients on a high ...
Viking's obesity-drug program is progressing well ... Viking Therapeutics is more than just a weight-loss stock, and that's drawing cheers The analysts are also upbeat on the amylin program ...
Anant Ambani and Radhika Merchant’s wedding was one of the most extravagant celebrations India has ever witnessed, drawing ...
An in-line performance of orforglipron could potentially result in a 5% decrease in Novo Nordisk's share price due to confirmed competition and the absence of a scalable oral obesity strategy.
Hosted on MSN8d
Why Alcohol Stocks’ Troubles Are Here to StayThat is drawing comparisons to tobacco and could add to industry challenges in coming years, but with alcohol, the government ...
Drawing parallels with a WWE wrestler or an athlete ... Dr Misra feels this breakdown is important for customising weight loss strategies. “We have bifurcated obesity into stages 1 (innocuous) and 2 ...
In this Personal View, we draw on evidence to support that weight loss is at least partly responsible (albeit to differing extents) for the reported benefits of incretin-based drugs for obesity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results